|
Sign In to gain access to subscriptions and/or personal tools.
|
Prevalence of RET/PTC Rearrangements in Hashimoto's Thyroiditis and Papillary Thyroid Carcinomas
Marina N. Nikiforova, MD
Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, OH, USA.
Christy M. Caudill, BS
Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, OH, USA.
Paul Biddinger, MD
Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, OH, USA.
Yuri E. Nikiforov, MD, PhD
Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, OH, USA.
The relationship between Hashimoto's thyroiditis (HT) and follicular cell-derived thy roid cancer remains unclear. Recently, 2 studies reported a 95% prevalence of RET/PTC rearrangements in histologically benign tissue affected by HT, suggesting that multiple occult tumors exist in HT patients with high frequency. We tested the prevalence of RET/PTC rearrangements in 26 HT, in 6 papillary carcinomas arising in the background of HT, and in 27 papillary carcinomas not associated with HT. We detected no RET/PTC rearrangements in HT or papillary carcinomas arising in the background of HT, in contrast to a 33% prevalence among papillary carcinomas not associated with HT. However, the expression of wild-type RET was found in more than half of papillary carcinomas. These results suggest that, if the association be tween HT and thyroid cancer exists, its molecular basis is different from RETIPTC rearrangement. Int J Surg Pathol 10(1):15-22, 2002
Key Words: thyroid Hashimito's thyroiditis papillary carcinoma RET gene RET/PTC rearrangement.
International Journal of Surgical Pathology, Vol. 10, No. 1,
15-22 (2002)
DOI: 10.1177/106689690201000104

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. R. Nasr, S. Mukhopadhyay, S. Zhang, and A.-L. A. Katzenstein
Absence of the BRAF Mutation in HBME1+ and CK19+ Atypical Cell Clusters in Hashimoto Thyroiditis: Supportive Evidence Against Preneoplastic Change
Am J Clin Pathol,
December 1, 2009;
132(6):
906 - 912.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Gupta-Abramson, A. B. Troxel, A. Nellore, K. Puttaswamy, M. Redlinger, K. Ransone, S. J. Mandel, K. T. Flaherty, L. A. Loevner, P. J. O'Dwyer, et al.
Phase II Trial of Sorafenib in Advanced Thyroid Cancer
J. Clin. Oncol.,
October 10, 2008;
26(29):
4714 - 4719.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Liu, P. Hou, M. Ji, H. Guan, K. Studeman, K. Jensen, V. Vasko, A. K. El-Naggar, and M. Xing
Highly Prevalent Genetic Alterations in Receptor Tyrosine Kinases and Phosphatidylinositol 3-Kinase/Akt and Mitogen-Activated Protein Kinase Pathways in Anaplastic and Follicular Thyroid Cancers
J. Clin. Endocrinol. Metab.,
August 1, 2008;
93(8):
3106 - 3116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. N. Nikiforova, G. C. Tseng, D. Steward, D. Diorio, and Y. E. Nikiforov
MicroRNA Expression Profiling of Thyroid Tumors: Biological Significance and Diagnostic Utility
J. Clin. Endocrinol. Metab.,
May 1, 2008;
93(5):
1600 - 1608.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A Salajegheh, E B Petcu, R A Smith, and A K-Y Lam
Follicular variant of papillary thyroid carcinoma: a diagnostic challenge for clinicians and pathologists
Postgrad. Med. J.,
February 1, 2008;
84(988):
78 - 82.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Riesco-Eizaguirre and P. Santisteban
New insights in thyroid follicular cell biology and its impact in thyroid cancer therapy
Endocr. Relat. Cancer,
December 1, 2007;
14(4):
957 - 977.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Zhu, R. Ciampi, M. N. Nikiforova, M. Gandhi, and Y. E. Nikiforov
Prevalence of RET/PTC Rearrangements in Thyroid Papillary Carcinomas: Effects of the Detection Methods and Genetic Heterogeneity
J. Clin. Endocrinol. Metab.,
September 1, 2006;
91(9):
3603 - 3610.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. B. de Groot, T. P. Links, J. T. M. Plukker, C. J. M. Lips, and R. M. W. Hofstra
RET as a Diagnostic and Therapeutic Target in Sporadic and Hereditary Endocrine Tumors
Endocr. Rev.,
August 1, 2006;
27(5):
535 - 560.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. E. Nikiforov
RET/PTC Rearrangement--A Link between Hashimoto's Thyroiditis and Thyroid Cancer...or Not
J. Clin. Endocrinol. Metab.,
June 1, 2006;
91(6):
2040 - 2042.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Rhoden, K. Unger, G. Salvatore, Y. Yilmaz, V. Vovk, G. Chiappetta, M. B. Qumsiyeh, J. L. Rothstein, A. Fusco, M. Santoro, et al.
RET/Papillary Thyroid Cancer Rearrangement in Nonneoplastic Thyrocytes: Follicular Cells of Hashimoto's Thyroiditis Share Low-Level Recombination Events with a Subset of Papillary Carcinoma
J. Clin. Endocrinol. Metab.,
June 1, 2006;
91(6):
2414 - 2423.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|